Search results
Results from the WOW.Com Content Network
Western Aphasia Battery (WAB) is an instrument for assessing the language function of adults with suspected aphasia as a result of a stroke, head injury, or dementia. The updated version is the Western Aphasia Battery-Revised (WAB-R). [1] The battery helps discern the presence, degree, and type of aphasia.
In order to capitalize on neuroplasticity for treatment of all types of aphasia, timing, intensity, duration, and repetition of treatment should be taken into consideration. Research has found that aphasia treatment initiated during the earlier acute post-injury phase is more effective compared to treatment initiated in the chronic phase. [21]
The Western Aphasia Battery assesses neurological disorders to discern the degree and type of aphasia present. The test also discerns a person's strengths and weaknesses, which can be used to treat the person better. Therapists should customize their treatment for each patient. The main focus for during speech therapy for conduction aphasia ...
Aphasia, also known as dysphasia, [a] is an impairment in a person’s ability to comprehend or formulate language because of damage to specific brain regions. [2] The major causes are stroke and head trauma; prevalence is hard to determine, but aphasia due to stroke is estimated to be 0.1–0.4% in developed countries. [3]
Aside from pain treatment, doctors may prescribe aspirin to patients who are at risk of heart attack or stroke, according to Harvard Health. These two serious health conditions occur when plaque ...
Quarterly sales of J&J's cancer drugs rose 19% worldwide, driven by more than $3 billion for multiple myeloma treatment Darzalex, which was up 20.9% from a year ago.
Paraphasia is associated with fluent aphasias, characterized by "fluent spontaneous speech, long grammatically shaped sentences and preserved prosody abilities." [4] Examples of these fluent aphasias include receptive or Wernicke's aphasia, anomic aphasia, conduction aphasia, and transcortical sensory aphasia, among others.
An off-label prescription drug has been shown to help children with autism gain the ability to speak. Leucovorin is used for cancer patients, but doctors are pushing for its approval for autism.